Your browser doesn't support javascript.
loading
Phenotypic assessment of antiviral activity for spiro-annulated oxepanes and azepenes.
Osolodkin, Dmitry I; Kozlovskaya, Liubov I; Iusupov, Ildar R; Kurkin, Alexander V; Shustova, Elena Y; Orlov, Alexey A; Khvatov, Evgeny V; Mutnykh, Elena S; Kurashova, Svetlana S; Vetrova, Anna N; Yatsenko, Darya O; Goryashchenko, Alexander S; Ivanov, Vladimir N; Lukyanenko, Evgeny R; Karpova, Evgenia V; Stepanova, Daria A; Volok, Viktor P; Sotskova, Svetlana E; Dzagurova, Tamara K; Karganova, Galina G; Lukashev, Alexander N; Ishmukhametov, Aydar A.
Affiliation
  • Osolodkin DI; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Kozlovskaya LI; Sechenov First Moscow State Medical University, Moscow, Russia.
  • Iusupov IR; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Kurkin AV; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Shustova EY; Sechenov First Moscow State Medical University, Moscow, Russia.
  • Orlov AA; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Khvatov EV; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Mutnykh ES; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Kurashova SS; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Vetrova AN; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Yatsenko DO; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Goryashchenko AS; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Ivanov VN; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Lukyanenko ER; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Karpova EV; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Stepanova DA; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Volok VP; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Sotskova SE; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Dzagurova TK; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Karganova GG; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Lukashev AN; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
  • Ishmukhametov AA; FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), Moscow, Russia.
Chem Biol Drug Des ; 103(5): e14553, 2024 May.
Article in En | MEDLINE | ID: mdl-38789394
ABSTRACT
Evolutionary potential of viruses can result in outbreaks of well-known viruses and emergence of novel ones. Pharmacological methods of intervening the reproduction of various less popular, but not less important viruses are not available, as well as the spectrum of antiviral activity for most known compounds. In the framework of chemical biology paradigm, characterization of antiviral activity spectrum of new compounds allows to extend the antiviral chemical space and provides new important structure-activity relationships for data-driven drug discovery. Here we present a primary assessment of antiviral activity of spiro-annulated derivatives of seven-membered heterocycles, oxepane and azepane, in phenotypic assays against viruses with different genomes, virion structures, and genome realization schemes orthoflavivirus (tick-borne encephalitis virus, TBEV), enteroviruses (poliovirus, enterovirus A71, echovirus 30), adenovirus (human adenovirus C5), hantavirus (Puumala virus). Hit compounds inhibited reproduction of adenovirus C5, the only DNA virus in the studied set, in the yield reduction assay, and did not inhibit reproduction of RNA viruses.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents Limits: Animals / Humans Language: En Journal: Chem Biol Drug Des Journal subject: BIOQUIMICA / FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents Limits: Animals / Humans Language: En Journal: Chem Biol Drug Des Journal subject: BIOQUIMICA / FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: